Interestingly, added frequencies of individual tumor-reactive TCRs in pLN, dLN, and TILs amounted to 22–34% of all CD4+Teff clones, but only to 5–13% of Treg clones in respective anatomical locations (Fig. 5). Here, CD4 is linked to neoplasm.